Apricus Biosciences Announces Pricing of $7.0 Million Public Offering

World News: . []

SAN DIEGO April 21 2017 GLOBE NEWSWIRE -- Apricus Biosciences Inc NasdaqAPRI a biopharmaceutical company advancing innovative medicines in urology and rheumatology today announced the pricing of an underwritten public offering of a n aggre...

More news and information about Apricus Biosciences, Inc.

Published By:

Thomson Reuters: 11:00 GMT Friday 21st April 2017

Published: .

Search for other references to "apricus" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers